IL10 and arthritic joint disease: The regulatory function of T2-MZP B cells has been first demonstrated in experimental arthritis model, and the realization of its regulatory effect depends on IL-10 mediation, inhibition the production of inflammatory cytokines, suppression of Ag-specific T cell activation, and reduction of Th1-type functional responses (56).